To everyone doubting Andrew’s decision to acquire TrialsWest and...

To everyone doubting Andrew’s decision to acquire TrialsWest and claiming he overpaid: let’s take a moment to consider the facts. Andrew has extensive expertise in mergers and acquisitions, honed during his time at Capitol Health. He clearly recognised the importance of having the right team in place to secure the $13.7 million contract with Sun Pharma—and he delivered.

Andrew is a leader who gets results. Yet, every day, we’re seeing small sell-offs in the retail market, dragging the stock down bit by bit. It’s death by a thousand cuts, and it’s entirely avoidable. Instead of feeding into the negativity, let’s focus on the immense potential this stock holds.

The road ahead promises to be an incredible journey, and I, for one, am here for the ride. Let’s stop undermining our own investment and start backing the vision.